Stay updated with breaking news from Gravis Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Richard and Helen DeVos Foundation announced Wednesday that it will sunset its work after supporting 1,044 nonprofit organizations in its 54 years of activity.
ZILBRYSQ® is now commercially available by prescription in the United States and dispensed by UCB's selected exclusive specialty pharmacy PANTHERx® Rare Pharmacy.ZILBRYSQ is FDA-approved as the...
UCB announces European Commission approval of ZILBRYSQ®▼ (zilucoplan) for the treatment of adults with generalized Myasthenia GravisEuropean approval of ZILBRYSQ® (zilucoplan) granted as an add-on to standard therapy for the treatment of generalized Myasthenia Gravis (gMG) in adult patients who are anti-acet...
UCB receives CHMP positive opinion for rozanolixizumab for treatment of adults with generalized myasthenia gravis in Europe The Committee for Medicinal...